A significant number of people are currently misusing and abusing anabolic steroids.
Hepatitis B, C, and HIV have all been documented to occur among anabolic steroid injectors (ASIs), most likely from the sharing of injection equipment.
A survey was administered to 42 needle exchange programs (NEPs) from 17 states in the US to determine ASI participation.
Sixty percent of the NEPs surveyed reported having at least some ASIs as participants, however, only 512 ASIs were identified among the 36 000 total monthly participants (1.4%). With the expanding number of NEPs in the US, it is possible to reach a higher proportion of ASIs with clean syringes and education, thus offering the means to prevent the spread of infection in this population.
Mots-clés Pascal : Abus, Consommation, Anabolisant, Hormone stéroïde sexuelle, Voie intraveineuse, Programme sanitaire, Prévention, Prise risque, Partage, Seringue, Infection, Hépatite virale, Virose, SIDA, Etats Unis, Amérique du Nord, Amérique, Homme, Immunopathologie, Immunodéficit
Mots-clés Pascal anglais : Abuse, Consumption, Anabolic agent, Sex steroid hormone, Intravenous administration, Sanitary program, Prevention, Risk taking, Sharing, Syringe, Infection, Viral hepatitis, Viral disease, AIDS, United States, North America, America, Human, Immunopathology, Immune deficiency
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0401251
Code Inist : 002B18H05A. Création : 22/03/2000.